✦ LIBER ✦

Erratum: Immunohistochemical Surrogate Markers of Breast Cancer Molecular Classes Predicts Response to Neoadjuvant Chemotherapy

✍ Scribed by Rohit Bhargava; Sushil Beriwal; David J. Dabbs; Umut Ozbek; Atilla Soran; Ronald R. Johnson; Adam M. Brufsky; Barry C. Lembersky; Gretchen M. Ahrendt

Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 38 KB
Volume: 117
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.25798

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunohistochemical surrogate markers of

Immunohistochemical surrogate markers of breast cancer molecular classes predicts response to neoadjuvant chemotherapy : A single institutional experience with 359 cases

✍ Rohit Bhargava; Sushil Beriwal; David J. Dabbs; Umut Ozbek; Atilla Soran; Ronald 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 191 KB

## Abstract ## BACKGROUND: Complete pathologic response to neoadjuvant chemotherapy (NACT) is predominantly seen in “ERBB2” and “basal‐like” tumors using expression profiling. We hypothesize that a similar response could be predicted using semiquantitative immunohistochemistry for estrogen recepto

Sequential assessment of multidrug resis

Sequential assessment of multidrug resistance phenotype and measurement of S-phase fraction as predictive markers of breast cancer response to neoadjuvant chemotherapy

✍ Sylvie Chevillard; Pierre Pouillart; Chérif Beldjord; Bernard Asselain; Philippe 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 698 KB

The authors examined the relevance of S-phase fraction (SPF) and multidrug resistance (MDR) phenotype as predictive tests of breast cancer response in a series of patients treated by conventional doses of neoadjuvant chemotherapy with (FAC) or without (FTC) doxorubicin. ## METHODS. Fine needle sa